Login / Signup

P53 in Penile Squamous Cell Carcinoma: A Pattern-Based Immunohistochemical Framework with Molecular Correlation.

Isabel TriasAdela SacoLorena MarimonRicardo López Del CampoCarolina ManzottiOriol OrdiMarta Del PinoFrancisco M PérezNaiara VegaSilvia AlósAntonio MartínezLeonardo Rodriguez-CarunchioOscar ReigPedro JaresCristina TeixidóTarek AjamiJuan Manuel Corral-MolinaFerran AlgabaMaría J RibalInmaculada Ribera-CortadaNatalia Rakislova
Published in: Cancers (2023)
p53 immunohistochemistry (IHC) has been proposed as a surrogate for TP53 mutations in penile squamous cell carcinomas (PSCC). We aimed to evaluate the performance of a pattern-based evaluation of p53 IHC in PSCC. Human papilloma virus (HPV) DNA testing, p16 and p53 IHC, and whole exome sequencing were performed in a series of 40 PSCC. p53 IHC was evaluated following a pattern-based framework and conventional p53 IHC evaluation. Out of 40 PSCC, 12 (30.0%) were HPV-associated, and 28 (70.0%) were HPV-independent. The agreement between the p53 IHC pattern-based evaluation and TP53 mutational status was almost perfect (k = 0.85). The sensitivity and accuracy of the pattern-based framework for identifying TP53 mutations were 95.5% and 92.5%, respectively, which were higher than the values of conventional p53 IHC interpretation (54.5% and 70.0%, respectively), whereas the specificity was the same (88.9%). In conclusions, the pattern-based framework improves the accuracy of detecting TP53 mutations in PSCC compared to the classical p53 IHC evaluation.
Keyphrases
  • squamous cell carcinoma
  • high grade
  • squamous cell
  • endothelial cells
  • prostate cancer
  • induced pluripotent stem cells
  • lymph node metastasis